Lung cancer risk in new pulmonary nodules: implications for CT screening and nodule management

Affiliations

¹ Respiratory Medicine Unit, David Evans Research Centre, Nottingham University Hospitals, Nottingham City Hospital Campus, Nottingham NG5 1PB, UK. Electronic address: david.baldwin@nuh.nhs.uk.
² Royal Brompton and Harefield NHS Foundation Trust, London, UK.

Comment

David R Baldwin et al. Lancet Oncol. 2016 Jul.

. 2016 Jul;17(7):849-850.

doi: 10.1016/S1470-2045(16)30134-6. Epub 2016 Jun 6.

¹ Respiratory Medicine Unit, David Evans Research Centre, Nottingham University Hospitals, Nottingham City Hospital Campus, Nottingham NG5 1PB, UK. Electronic address: david.baldwin@nuh.nhs.uk.
² Royal Brompton and Harefield NHS Foundation Trust, London, UK.

No abstract available

Comment on

Occurrence and lung cancer probability of new solid nodules at incidence screening with low-dose CT: analysis of data from the randomised, controlled NELSON trial.
Walter JE, Heuvelmans MA, de Jong PA, Vliegenthart R, van Ooijen PMA, Peters RB, Ten Haaf K, Yousaf-Khan U, van der Aalst CM, de Bock GH, Mali W, Groen HJM, de Koning HJ, Oudkerk M. Walter JE, et al. Lancet Oncol. 2016 Jul;17(7):907-916. doi: 10.1016/S1470-2045(16)30069-9. Epub 2016 Jun 6. Lancet Oncol. 2016. PMID: 27283862 Clinical Trial.